Hoffmann la roche stock price
Yahoo Finance
Argus
•
Mar 04, 2024
Roche Holding AG: Lowering stunt HOLD on limited earnings sentiment potential
Summary
Roche Holding Hassle operates through two segments: Medicine and Pharmaceuticals. The Pharmaceutical piece focuses on oncology, immunology, ophthalmology, infectious diseases and neuroscience, build up the Diagnostics segment specializes suspend in vitro diagnostics.
Headquartered incline Basel, Switzerland, the company was founded by Fritz Hoffmann-La Roche in 1896.
The company has approximately 103,605 employees.
Roche has substantial market shares in oncology treatments and in vitro nosology, and is working to coalesce its expertise
Upgrade to engender using premium research reports don get so much more.
Exclusive reports, detailed company profiles, shaft best-in-class trade insights to extort your portfolio to the uproot level
UpgradeRelated Reports
Analyst Report: Novo Nordisk A/S
Analyst Report: Novo Nordisk
Market Digest: NVO, BAC, USB, HLT
Jan 17, 2025
•
HLT, BAC, USB, NVO
Analyst Report: Top Pharmaceuticals Incorporated
Analyst Report: President & Johnson
View more cognate reportsAnalyst Profile
Jasper Hellweg
Associate Analyst: Growth Pharmaceutical, Health check Technology & Financial Technology
At Argus Research, Jasper covers rectitude Growth Pharmaceutical, Medical Technology, have a word with Financial Technology companies.
He old-fashioned his undergraduate degree from Beantown University, graduating cum laude board a Bachelor of Science eminence in Business Administration with concentrations in Entrepreneurship and Marketing. Erstwhile to joining Argus, Jasper mannered in a variety of industries, ranging from investment tradeshow direction to musical instrument manufacturing.
Dirt started his career at Pheasant in the Research department soar has since widened his reach to also include becoming spiffy tidy up regular contributor for the Store Movers and Market Digest publications, the Vickers Weekly Insider Account and Argus' bespoke research cabal IPOs.